Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2025-12-30 @ 2:49 AM
Study NCT ID:
NCT07181161
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2025-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-18
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-12
First Submit QC Date:
None
Study First Post Date:
2025-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED